Navjeewan Khosla

Navjeewan Khosla is a seasoned professional in the healthcare investment and technology sectors, currently serving as a Management Advisor at 2Strands Biosciences since January 2025, and as a Partner at Novo Holdings since August 2021. Navjeewan holds board positions with AgNext, Halodoc, MEDGENOME, and Qure.ai, reflecting a commitment to advancing healthcare accessibility and innovation. Previous experience includes serving as a Director at Quadria Capital, where focus was on high-growth healthcare investments in South Asia and Southeast Asia, and as Managing Director at Fosun Health Holdings, leading investment strategies in the region. An MBA graduate from the Indian Institute of Management Ahmedabad and a B Tech in Mechanical Engineering from the Indian Institute of Technology, Kharagpur, Navjeewan also completed a course on Sustainable and Impact Investment from US SIF.